Q15910 |
EZH2_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q15910 |
EZH2_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
Q15910 |
EZH2_HUMAN |
Follicular lymphoma [ICD-11: 2A80] |
Q15910 |
EZH2_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
Q15910 |
EZH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q15910 |
EZH2_HUMAN |
Synovial sarcoma [ICD-11: 2B5A] |
Q15910 |
EZH2_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q15910 |
EZH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q15910 |
EZH2_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
Q15910 |
EZH2_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q15910 |
EZH2_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
Q15910 |
EZH2_HUMAN |
Ureteral cancer [ICD-11: 2C92] |
Q15910 |
EZH2_HUMAN |
B-cell lymphoma [ICD-11: 2A86] |
Q15910 |
EZH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
Q15910 |
EZH2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q15910 |
EZH2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16665 |
HIF1A_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 |
HIF1A_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q16665 |
HIF1A_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
Q16665 |
HIF1A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |